The impact of recurrence score (RS) performed on pretreatment (Tx) core biopsies (CB) in predicting response to neoadjuvant chemotherapy (NCT) in patients (Pts) with ER+ breast cancer (BC).
Atilla Soran
Research Funding - Genomic Health
Kandace P. McGuire
No relevant relationships to disclose
Gretchen Ahrendt
No relevant relationships to disclose
Marguerite Bonaventura
No relevant relationships to disclose
Priscilla F. McAuliffe
No relevant relationships to disclose
Emilia Diego
No relevant relationships to disclose
Merida Serrano
No relevant relationships to disclose
Ronald Johnson
No relevant relationships to disclose